Clostridia Clusters XIVa

If you have taken broad-spectrum antibiotics, been through chemotherapy, or spent time in a hospital, one specific group of gut bacteria takes the hardest hit. In critically ill adults, the share of the gut occupied by Clostridia clusters IV and XIVa (the Clostridium coccoides-Eubacterium rectale group) fell from about 2.6% to 0.30% within 72 hours of admission, and the people who lost them were the ones whose guts filled up with drug-resistant Enterococcus.

These are among the most abundant residents of a healthy colon, and despite the Clostridium in the name they are nothing like the pathogen most people associate with it. They make the short-chain fatty acid butyrate, which your colon cells burn for energy. This test counts them. It is a research-grade measurement without standardized clinical cutpoints, so treat the number as a window into one specific gut function rather than a diagnosis.

What This Group Actually Is

Cluster XIVa is a family tree, not a single organism. It is one branch of the gut's bacterial family tree, and it gathers together genera you may have seen on other gut reports: Roseburia, Blautia, Coprococcus, Dorea, Anaerostipes, Fusicatenibacter, and Eubacterium rectale. Together with the related cluster IV, these organisms make up somewhere between 10% and 40% of the entire human gut community.

They are strict anaerobes. They live in the colon, they cannot tolerate oxygen, and they earn their keep by fermenting the complex carbohydrates you cannot digest yourself. In healthy adults they number in the billions of cells per gram of stool, and that level holds reasonably steady in a given person over months.

Butyrate and Your Colon Lining

The reason anyone measures this group is butyrate. Butyrate feeds the cells lining your colon directly and helps keep the barrier between gut contents and bloodstream tight. It also drives the development of regulatory T cells, the immune cells that tell the rest of your immune system to stand down, though that part of the story rests largely on mouse experiments. Cut the butyrate supply and all three of those jobs are expected to suffer at once.

This is why a low count is worth paying attention to even without symptoms. It is not that a number on a page is dangerous. It is that the metabolic work these bacteria do has no obvious substitute in most people's guts, and when the work stops, the colon lining is the first thing to notice.

Bile Acid Conversion

A subset of cluster XIVa members do a second job that almost nothing else in the gut can do: they convert primary bile acids released by your liver into secondary bile acids. The link between the group and that chemistry is tight. In a study of about 100 adults, fecal cluster XIVa abundance tracked the ratio of unconjugated deoxycholic acid to total cholates with a correlation of 0.77, a strong but imperfect relationship, where 1.0 would mean the two move in perfect lockstep.

That correlation is strong enough that bile acid profiles in stool or blood have been proposed as an indirect readout of how much cluster XIVa you have. Practically, it means a low count here is not an isolated microbiology curiosity. It usually comes with a measurable shift in the chemistry of your gut.

Inflammatory Bowel Disease

Active Crohn's disease and ulcerative colitis both show depleted cluster XIVa. The depletion is not uniform across the whole group; specific members thin out. Fusicatenibacter saccharivorans and Roseburia intestinalis drop in ulcerative colitis, and Fusicatenibacter in particular induced interleukin-10, an anti-inflammatory signal, in laboratory experiments on cells taken from the gut lining.

The most telling evidence comes from fecal microbiota transplantation for ulcerative colitis. Patients who reached long-term remission were the ones whose guts took up donor-derived cluster XIVa organisms and their butyrate-making machinery. Patients who did not establish those organisms relapsed. That does not prove cluster XIVa causes remission, but it is closer to cause than a snapshot comparison ever gets.

Antibiotics, Chemotherapy, and Losing Your Defenses

Broad-spectrum antibiotics are the single clearest driver of collapse. In ICU patients, antibiotic exposure roughly tripled the odds of cluster XIVa depletion after accounting for other factors, and the depletion came with lower microbial diversity and overgrowth of vancomycin-resistant Enterococcus.

Chemotherapy does something similar on a slower timeline. In one small study of adults on cancer treatment, this group thinned out alongside a drop in overall diversity and greater vulnerability to Clostridioides difficile. The concept at work here is colonization resistance: a full, metabolically active colon leaves no room and no fuel for opportunists. Empty it out and something else moves in.

This also shows up in recovery from C. difficile. After treatment for a first infection, patients who avoided a second one had recovered more of their cluster XIVa organisms, including bile-acid-converting species such as Clostridium scindens, than the patients who relapsed.

Cystic Fibrosis and Nutrition

In a small study, children with cystic fibrosis carried markedly fewer of these bacteria than healthy controls, and the abundance tracked their weight-for-height, a measure of nutritional status. Repeated antibiotic courses are the likely reason the suppression persists.

Multiple Sclerosis

In a small Japanese cohort, people with multiple sclerosis showed depletion of 14 specific species within clusters XIVa and IV, and the depleted species overlapped heavily with strains identified in mouse work as inducers of regulatory T cells. The direction of causation is unresolved, and findings vary across different ethnic and treatment groups. Treat this as an association worth knowing about, not a diagnostic signal.

When Higher Is Not Better

Most of the evidence points one way: less is worse. But a handful of studies report the opposite. Some taxa within cluster XIVa have been found at higher levels in people with obesity-related metabolic abnormalities including dyslipidemia and higher serum uric acid, and in oral squamous cell carcinoma, higher subcluster XIVa was seen alongside worse survival in a small study.

These findings do not contradict the butyrate story so much as reframe what the number means. This is not a marker where a bigger number is automatically a better score. It is a readout of how much of a particular fermentation ecosystem you have, and the same ecosystem can be favorable in the context of an inflamed colon and unhelpful in the context of metabolic disease or an established tumor. Read the number next to your own clinical situation, not against an imagined ideal.

Why a Single Reading Can Fool You

How much weight to put on your result depends on this. Individual genera in the gut swing enormously day to day. Quantitative daily profiling found that many gut genera vary as much within one person over six weeks as they do between different people, with some swinging up to a hundredfold. Clostridial lineages specifically vary by 30% or more between consecutive stools, and sometimes far more.

Two things drive most of that noise. Transit time and stool moisture shift the apparent concentration of everything in the sample. And DNA extraction technique matters a great deal for these organisms in particular, because gram-positive Firmicutes have tough cell walls and how hard the lab beats the sample open changes how many it recovers. That means results from two different labs are not directly comparable.

Your broader community profile is steadier than any single genus. In 308 men followed for six months, a single stool sample captured long-term organismal composition and functional potential well. So a single reading tells you roughly where your gut ecosystem sits. It does not reliably tell you whether this one group moved 30% since last month.

• Recent antibiotics: a course within the past several weeks can drive this group far below your normal baseline, and the reading will reflect the drug rather than your usual gut.
• Acute illness or hospitalization: depletion happens within 72 hours of ICU admission, so a sample collected during or just after a serious illness is not representative.
• Diet in the days before collection: fermentable carbohydrate intake moves this group measurably, so a low-carbohydrate week before sampling will read lower than your habitual state.
• Lab method: DNA extraction protocol accounts for meaningful variation in recovering these bacteria, so stick with one lab if you plan to compare over time.

Tracking Your Trend

Given that variability, a single number is a starting point and nothing more. Get a baseline when you are not acutely ill and not within a few weeks of antibiotics. If you are changing your diet or recovering from an antibiotic course, retest in three to six months. After that, annually is reasonable if you are tracking gut health as part of a broader picture.

The trend is where this test earns its keep. A count that recovers over six months after antibiotics tells you your gut ecosystem rebuilt itself. A count that stays flat tells you it did not, and that is worth knowing. If you are trying to confirm that a dietary change worked, retest at the same lab using the same collection method, because switching either one will produce a difference that has nothing to do with your gut.

What to Do With an Unexpected Result

A low count on its own, in someone who feels fine, is a reason to track and to think about fiber, not a reason to treat anything. What makes it actionable is the company it keeps. Order fecal or serum bile acid profiling alongside it, since the link between this group and secondary bile acid conversion is strong enough that both measurements pointing the same direction is more informative than either alone.

If you have digestive symptoms, add fecal calprotectin to check for actual intestinal inflammation, and a pancreatic elastase measurement if you suspect poor digestion rather than a microbial problem. Low cluster XIVa plus elevated calprotectin plus loose stools is a pattern that warrants a gastroenterologist, not more microbiome testing. Low cluster XIVa with normal calprotectin and no symptoms is a pattern to watch.

One thing this test does not do: it says nothing about whether you have a C. difficile infection. Those are entirely different organisms detected by entirely different assays targeting toxin genes. If you have new persistent diarrhea after antibiotics, you need a toxigenic C. difficile test, not this one.

How Mature Is This Measurement

Be clear-eyed about what you are buying. There are no validated reference ranges for cluster XIVa. Baseline abundance varies widely across healthy people, across geography, and across sampling and extraction methods, and no randomized trial has shown that measuring it and acting on the result improves any outcome. It has not been shown to catch disease earlier in healthy people.

That is exactly why a baseline now is worth having. The underlying biology is well established: these bacteria make butyrate, some of them convert bile acids, and antibiotics wipe them out. What is missing is the interpretive scaffolding. If you start tracking now, you will have your own multi-year series to read against whenever the reference data catch up.